Stifel Maintains Hold on Edwards Lifesciences, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Hold rating on Edwards Lifesciences (NYSE:EW) and lowers the price target from $85 to $70.

July 25, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst Rick Wise maintains a Hold rating on Edwards Lifesciences and lowers the price target from $85 to $70, indicating a more cautious outlook on the stock.
The lowered price target from $85 to $70 by Stifel suggests a more cautious outlook on Edwards Lifesciences' future performance. This could lead to a short-term negative impact on the stock price as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100